[Federal Register Volume 62, Number 148 (Friday, August 1, 1997)]
[Notices]
[Page 41389]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-20310]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): 1997 Extramural Applied Research Program in 
Emerging Infections--Novel Methods for Identification of Emerging 
Infections, Program Announcement 778: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Disease, Disability, and Injury Prevention and Control 
SEP: 1997 Extramural Applied Research Program in Emerging 
Infections--Novel Methods for Identification of Emerging Infections, 
Program Announcement 778.
    Time and Dates: 8:30 a.m.-4:30 p.m., August 25-29, 1997.
    Place: Centers for Disease Control and Prevention, 1600 Clifton 
Road, N.E., Atlanta, Georgia 30333.
    Status: Closed.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement 778.
    The meeting will be closed to the public in accordance with 
provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Associate Director for Management and 
Operations, CDC, pursuant to Pub. L. 92-463.
    Contact Person for More Information: Gregory J. Jones, M.P.A., 
Office of the Director, National Center for Infectious Diseases, 
CDC, M/S C19, 1600 Clifton Road, N.E., Atlanta, Georgia 30333, 
telephone 404/639-2434.

    Dated: July 25, 1997.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 97-20310 Filed 7-31-97; 8:45 am]
BILLING CODE 4163-18-P